EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proton pump inhibitors and the risk of hospital acquired clostridioides difficile infection in critically ill patients

Qian Zeng, Chengfu Guan, Jiana Chen, Li Chen

Frontiers in Pharmacology · 13.07.2026 · 17

DOI: 10.3389/fphar.2026.1829764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.07.2026. Verfasst von Qian Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proton pump inhibitors (PPIs) are commonly prescribed medications for critically ill patients. However, the existence of a clear association between PPI prescriptions and Clostridioides difficile infection (CDI) remains controversial. This study aims to investigate the relationship between PPI use and CDI, thereby providing additional evidence for the clinical application of PPIs.

Methods

This study extracted data from the eICU and MIMIC IV databases, ultimately enrolling 26,090 patients. Propensity score matching was employed to balance covariates across groups. Clinical outcomes were compared using χ 2 tests after matching, and specific risk factors were analyzed via multivariate logistic regression, with results presented as odds ratios and 95% confidence intervals.

Results

Compared with the non-PPI group, the PPI group showed a significantly increased risk of CDI (PPI vs. No-PPI: 2.6% vs. 1.6%; OR, 1.70; 95% CI, 1.43–2.02; p < 0.001). Across all subgroups, the risk of CDI was significantly higher in the PPI group than in the non-PPI group. Obesity (BMI ≥ 30), cancer, diabetes, IBD, kidney disease, and use of high-risk antibiotics were significantly associated with increased CDI risk in patients.

Conclusion

Among critically ill patients, PPI recipients exhibited a significantly increased risk of CDI compared to those not using PPIs.

Schlagwörter

Stichwörter der Autor:innen

Clostridioides difficile infectionadverse reactionscritically illintensive care unitproton pump inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China.

Förderung

  • Fujian Medical University

Zitieren

APA

Zeng, Q., Guan, C., Chen, J., & Chen, L. (2026). Proton pump inhibitors and the risk of hospital acquired clostridioides difficile infection in critically ill patients. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1829764

Vancouver

Zeng Q, Guan C, Chen J, Chen L. Proton pump inhibitors and the risk of hospital acquired clostridioides difficile infection in critically ill patients. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1829764

BibTeX
@article{Zeng2026,
  author = {Zeng, Qian and Guan, Chengfu and Chen, Jiana and Chen, Li},
  title = {Proton pump inhibitors and the risk of hospital acquired clostridioides difficile infection in critically ill patients},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1829764}
}
Kostenlos starten →